Felipe Lino
Co-Founder & Chief Technology Officer Nosh.bio
PhD-trained biotechnologist (DTU) with 15+ years advancing industrial solutions at Novozymes, AB InBev, and startups. Spearheaded biological solutions for Brazil’s $60B bioethanol industry at Novozymes, securing patents for fermentation efficiency. As AB InBev’s Global R&D Manager, transformed brewery byproducts into premium ingredients through circular bioeconomy initiatives. Co-founded Nosh.bio to industrialize microbial fermentation, engineering the first single-ingredient meat analog (koji protein) using retrofitted brewery infrastructure—enabling rapid scale to 5-10k tons/year. Secured more than €3M in funding and strategic partnerships with VCs and multinational food leaders.
Seminars
Thursday 23rd October 2025
Retrofitting Facilities from Other Industries to Reduce Capex Costs & Timelines
10:00 am
- Outlining a case study of retrofitting a beer facility to create an industrial scale mycoprotein production plant
- Exploring how to balance production in owned and contract manufacturing facilities
- Integrating variability into initial facility design to enable future adaptation
